These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12942715)

  • 1. Antineutrophil cytoplasmic antibodies (ANCA) in ankylosing spondylitis.
    Calvo-Romero JM; Romero-Requena J; Arévalo-Lorido JC
    Clin Exp Rheumatol; 2003; 21(4):528. PubMed ID: 12942715
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis.
    Koh WH; Dunphy J; Dixey J; Calin A; McHugh NJ; Maddison PJ
    Br J Rheumatol; 1995 Jul; 34(7):695-6. PubMed ID: 7670800
    [No Abstract]   [Full Text] [Related]  

  • 3. Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.
    Matzkies FG; Targan SR; Berel D; Landers CJ; Reveille JD; McGovern DP; Weisman MH
    Arthritis Res Ther; 2012 Nov; 14(6):R261. PubMed ID: 23194008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are antineutrophil cytoplasmic antibodies associated with spondyloarthropathies?
    Weinerth JD; Stoffel MP; Csernok E; Gross WL
    Br J Rheumatol; 1996 Oct; 35(10):1032-3. PubMed ID: 8883450
    [No Abstract]   [Full Text] [Related]  

  • 5. pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.
    de Vries M; van der Horst-Bruinsma I; van Hoogstraten I; van Bodegraven A; von Blomberg BM; Ratnawati H; Dijkmans B
    J Rheumatol; 2010 Nov; 37(11):2340-4. PubMed ID: 20810508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis.
    Mareen P; Van De Walle S; Bernaert P; Vanhouteghem H; Dierick J
    Acta Clin Belg; 2003; 58(3):193-200. PubMed ID: 12945480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of cytoplasmic ANCA (cANCA) and other autoantibodies in leprosy patients from western India.
    Pradhan V; Badakere SS; Shankar Kumar U
    Lepr Rev; 2004 Mar; 75(1):50-6. PubMed ID: 15072126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of ANCA and ASCA in inflammatory bowel disease.
    Targan SR
    Inflamm Bowel Dis; 1999 Feb; 5(1):61-3; discussion 66-7. PubMed ID: 10028450
    [No Abstract]   [Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis.
    Manolova I; Dancheva M
    J Rheumatol; 2003 Sep; 30(9):2078-9; author reply 2079-80. PubMed ID: 12966621
    [No Abstract]   [Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis.
    Carvajal I; Bernis C; Sanz P; Garcia A; Garcia-Vadillo A; Traver JA
    Nephrol Dial Transplant; 1997 Mar; 12(3):576-7. PubMed ID: 9075145
    [No Abstract]   [Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus in childhood.
    Faure-Fontenla MA; Rodríguez-Suárez RS; Arias-Velásquez R; García-González JE
    J Rheumatol; 1999 Nov; 26(11):2480-1. PubMed ID: 10555913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application.
    Sinico RA; Radice A
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S112-7. PubMed ID: 24854381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of direct immunofluorescence test in cutaneous leukocytoclastic vasculitis.
    Sais G; Vidaller A
    Int J Dermatol; 2005 Nov; 44(11):970-1; author reply 971. PubMed ID: 16336539
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases.
    Roozendaal C; Kallenberg CG
    Hepatogastroenterology; 1999; 46(30):3034-40. PubMed ID: 10626156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antineutrophil cytoplasmic antibody (ANCA) and vasculitis].
    Yoshida M
    Ryumachi; 1995 Dec; 35(6):934-42. PubMed ID: 8720273
    [No Abstract]   [Full Text] [Related]  

  • 16. P-ANCA for ulcerative colitis management-hype or hope?
    Koch TR
    Am J Gastroenterol; 2002 Feb; 97(2):485. PubMed ID: 11866293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
    Hagemo JS; Aasarød K; Moen T
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies to brush-border antigens in ankylosing spondylitis].
    Hrncír Z; Nozicka Z; Bradna P
    Cas Lek Cesk; 1988 Jan; 127(3):84-5. PubMed ID: 3258190
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
    Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
    J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.